药物之间的相互作用1329045个记录(本栏目收费,不能展示细节,电话13136136841)
药物之间的相互作用
Panitumumab
Potassium alum
The serum concentration of cis-Diamminechlorocholylglycinateplatinum(II) can be decreased when it is combined with Potassium alum.
Panitumumab
Magaldrate
The serum concentration of cis-Diamminechlorocholylglycinateplatinum(II) can be decreased when it is combined with Magaldrate.
Panitumumab
Aluminum hydroxide
The serum concentration of cis-Diamminechlorocholylglycinateplatinum(II) can be decreased when it is combined with Aluminum hydroxide.
Panitumumab
Kaolin
The serum concentration of cis-Diamminechlorocholylglycinateplatinum(II) can be decreased when it is combined with Kaolin.
Panitumumab
Nomegestrol acetate
The therapeutic efficacy of cis-Diamminechlorocholylglycinateplatinum(II) can be decreased when used in combination with Nomegestrol acetate.
Panitumumab
Demegestone
The therapeutic efficacy of cis-Diamminechlorocholylglycinateplatinum(II) can be decreased when used in combination with Demegestone.
Panitumumab
Quingestanol
The therapeutic efficacy of cis-Diamminechlorocholylglycinateplatinum(II) can be decreased when used in combination with Quingestanol.
Panitumumab
Norgestrienone
The therapeutic efficacy of cis-Diamminechlorocholylglycinateplatinum(II) can be decreased when used in combination with Norgestrienone.
Panitumumab
Chlormadinone
The therapeutic efficacy of cis-Diamminechlorocholylglycinateplatinum(II) can be decreased when used in combination with Chlormadinone.
Panitumumab
Ormeloxifene
The therapeutic efficacy of cis-Diamminechlorocholylglycinateplatinum(II) can be decreased when used in combination with Ormeloxifene.
Panitumumab
Lynestrenol
The therapeutic efficacy of cis-Diamminechlorocholylglycinateplatinum(II) can be decreased when used in combination with Lynestrenol.
Panitumumab
Gestrinone
The therapeutic efficacy of cis-Diamminechlorocholylglycinateplatinum(II) can be decreased when used in combination with Gestrinone.
Panitumumab
Norgestrel
The therapeutic efficacy of cis-Diamminechlorocholylglycinateplatinum(II) can be decreased when used in combination with Norgestrel.
Panitumumab
Norethynodrel
The therapeutic efficacy of cis-Diamminechlorocholylglycinateplatinum(II) can be decreased when used in combination with Norethynodrel.
Panitumumab
Dienogest
The therapeutic efficacy of cis-Diamminechlorocholylglycinateplatinum(II) can be decreased when used in combination with Dienogest.
Panitumumab
Gestodene
The therapeutic efficacy of cis-Diamminechlorocholylglycinateplatinum(II) can be decreased when used in combination with Gestodene.
Panitumumab
Cyproterone acetate
The therapeutic efficacy of cis-Diamminechlorocholylglycinateplatinum(II) can be decreased when used in combination with Cyproterone acetate.
Panitumumab
Drospirenone
The therapeutic efficacy of cis-Diamminechlorocholylglycinateplatinum(II) can be decreased when used in combination with Drospirenone.
Sinecatechins
Aluminium phosphate
The serum concentration of Bamet-UD2 can be decreased when it is combined with Aluminium phosphate.
Sinecatechins
Montmorillonite
The serum concentration of Bamet-UD2 can be decreased when it is combined with Montmorillonite.